NINDS Neuroscience Funding Announcements

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.

---

Exploratory/Developmental Projects in Translational Research for Neuromuscular Disease (R21)
Release Date: August 5, 2008
Announcement Number: PAR-08-228
Application Receipt Date:
October 16, 2008
February 16, 2009
June 16, 2009
October 16, 2009
February 16, 2010
June 16, 2010
October 16, 2010
February 16, 2011
June 16, 2011   

Funding Contact: John Porter, Ph.D.
Program Area: Neurogenetics

Brief Description:
This Funding Opportunity Announcement (FOA), from the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), requests applications for projects intended to complete preliminary steps in the pipeline for the preclinical development of therapeutics for neuromuscular diseases. Such projects, if successful, should lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). Only Aims required for therapy development can be supported in this program. This program excludes clinical research, basic research, and studies of disease mechanisms.

Choose an option to view additional funding announcements

New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives